Author:
Kruthika K.R.,Rajeswari ,Maheshappa H.D.
Funder
AD Neuroimaging Initiative
National Institutes of Health
DOD
ADNI
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
AbbVie
Alzheimer's Association
Alzheimer's Drug Discovery Foundation
Araclon Biotech
BioClinica
Biogen
Bristol-Myers Squibb Company
CereSpir, Inc
Cogstate
Eisai
Pharmaceuticals
Eli Lilly and Company
EuroImmun
F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc
Fujirebio
GE Healthcare
IXICO Ltd
Janssen Alzheimer Immunotherapy Research Development, LLC
Johnson Johnson Pharmaceutical Research Development LLC
Lumosity
Lundbeck
Merck
Meso Scale Diagnostics, LLC
NeuroRx Research
Neurotrack Technologies
Novartis Pharmaceuticals Corporation
Pfizer
Piramal Imaging
Servier
Takeda Pharmaceutical Company
Transition Therapeutics
Canadian Institutes of Health Research
ADNI clinical sites in Canada
Foundation for the National Institutes of Health
Northern California Institute for Research and Education
Reference50 articles.
1. Is the risk of Alzheimer's disease and dementia declining?;Langa;Alzheimer's Res Ther,2015
2. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census;Hebert;Neurology,2013
3. The worldwide economic impact of dementia 2010;Wimo;Alzheimer's Dementia,2013
4. Hinton. Imagenet classification with deep convolutional neural networks;Krizhevsky,2016
5. Deep residual learning for image recognition;He,2016
Cited by
105 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献